Anne-Marie Taburet
Overview
Explore the profile of Anne-Marie Taburet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertrand J, Barrail-Tran A, Fayette L, Savic R, Goujard C, Teicher E, et al.
Antimicrob Agents Chemother
. 2023 Apr;
67(5):e0233918.
PMID: 37098914
Tenofovir (TFV) and emtricitabine (FTC) are part of the recommended highly active antiretroviral therapy (ART). Both molecules show a large interindividual pharmacokinetic (PK) variability. Here, we modeled the concentrations of...
2.
Gele T, Cheret A, Gordon A, Nkam L, Furlan V, Pallier C, et al.
J Antimicrob Chemother
. 2021 Sep;
76(12):3280-3285.
PMID: 34508640
Objectives: The penetration of antiretroviral drugs into deep compartments, such as the CNS, is a crucial component of strategies towards an HIV cure. This study aimed to determine CSF concentrations...
3.
Gele T, Gouget H, Furlan V, Becker P, Taburet A, Lambotte O, et al.
Antimicrob Agents Chemother
. 2020 Sep;
64(11).
PMID: 32868324
This study aimed to characterize dolutegravir (DTG) and bictegravir (BIC) binding. They had a preferential binding to human serum albumin (HSA) with two classes of albumin sites. Human alpha-1-acid glycoprotein...
4.
Malvy D, Taburet A, de Lamballerie X, Mentre F, Extramiana F
PLoS Negl Trop Dis
. 2020 Jun;
14(6):e0008259.
PMID: 32584817
No abstract available.
5.
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial
Atwine D, Baudin E, Gele T, Muyindike W, Mworozi K, Kyohairwe R, et al.
J Antimicrob Chemother
. 2020 Jan;
75(5):1250-1258.
PMID: 31999314
Background: High-dose rifampicin is considered to shorten anti-TB treatment duration but its effect on antiretroviral metabolism is unknown. Objectives: To assess the effect of doubling the rifampicin dose (to 20 ...
6.
Barrail-Tran A, Goldwirt L, Gele T, Laforest C, Lavenu A, Danjou H, et al.
Eur J Clin Pharmacol
. 2019 Aug;
75(11):1555-1563.
PMID: 31384986
Purpose: Direct-acting antiviral agents have demonstrated their efficacy in treating HCV recurrence after liver transplantation and particularly the sofosbuvir/daclatasvir combination. Pharmacokinetic data on both calcineurin inhibitors and direct-acting antiviral exposure...
7.
Gele T, Furlan V, Taburet A, Pallier C, Becker P, Goujard C, et al.
Open Forum Infect Dis
. 2019 Jun;
6(6):ofz174.
PMID: 31198814
This study aimed to determine dolutegravir cerebrospinal fluid (CSF) diffusion in 13 patients with HIV-related cerebral impairment enrolled in a real-life observational study. Dolutegravir median (range) CSF concentration [9.6 (3.6-22.8)...
8.
Gonzales E, Matarazzo L, Franchi-Abella S, Dabadie A, Cohen J, Habes D, et al.
Orphanet J Rare Dis
. 2018 Oct;
13(1):190.
PMID: 30373615
Background: Oral cholic acid (CA) replacement has been shown to be an effective therapy in children with primary bile acid synthesis defects, which are rare and severe genetic liver diseases....
9.
Atwine D, Bonnet M, Taburet A
Br J Clin Pharmacol
. 2018 Apr;
84(8):1641-1658.
PMID: 29624706
Aims: Efavirenz (EFV) and rifampicin-isoniazid (RH) are cornerstone drugs in human immunodeficiency virus (HIV)-tuberculosis (TB) coinfection treatment but with complex drug interactions, efficacy and safety challenges. We reviewed recent data...
10.
Madelain V, Guedj J, Mentre F, Nguyen T, Jacquot F, Oestereich L, et al.
Antimicrob Agents Chemother
. 2017 Dec;
62(1).
PMID: 29269432
No abstract available.